The efficacy of procedure was evaluated by IPSS (International Prostate Symptom Score) and uroflowmetry. Results: Mean age 76.2±8.4 years, mean PSA 92.5±47.2 ng / mL, bone metastases 32/34 (94.1%) patients. Of the 32/34 (94.1%) patients who voided successfully after a catheter-free trial.